TY - JOUR
T1 - Necroptotic extracellular vesicles – present and future
AU - Raden, Yael
AU - Shlomovitz, Inbar
AU - Gerlic, Motti
N1 - Funding Information: This work was supported by the Recanati Foundation (TAU); Israel Science Foundation (ISF) under Grants #1416/15 and 818/18; Alpha-1 foundation under Grant #615533; U.S. ? Israel Binational Science Foundation (BSF) under Grant #2017176; Individual research grant from Varda and Boaz Dotal Research Center in Hemato-Oncology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript. Funding Information: This work was supported by the Recanati Foundation (TAU) ; Israel Science Foundation (ISF) under Grants #1416/15 and 818/18 ; Alpha-1 foundation under Grant #615533 ; U.S. – Israel Binational Science Foundation (BSF) under Grant #2017176 ; Individual research grant from Varda and Boaz Dotal Research Center in Hemato-Oncology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript. Publisher Copyright: © 2020 Elsevier Ltd
PY - 2021/1
Y1 - 2021/1
N2 - Necroptosis is a receptor-interacting protein kinase 3 (RIPK3)-/mixed lineage kinase domain-like(MLKL)-dependent and caspase-independent form of cell death that promotes inflammation. We, and others, have recently shown that necroptotic cells release extracellular vesicles (EVs). This finding has highlighted that the impact of necroptosis extends well beyond its cell death function. In this review, we summarize the general characteristics, biogenesis, and function of EVs, as well as their role in cancer. In addition, we outline our current knowledge regarding necroptotic EVs, including their recently discovered and analyzed proteome. We examine the accumulating evidence for a role for necroptosis in anti-tumor immunity. Finally, we suggest that necroptotic EVs play an important role in the necroptosis-induced immune response and may, therefore, be exploited in cancer immunotherapy applications.
AB - Necroptosis is a receptor-interacting protein kinase 3 (RIPK3)-/mixed lineage kinase domain-like(MLKL)-dependent and caspase-independent form of cell death that promotes inflammation. We, and others, have recently shown that necroptotic cells release extracellular vesicles (EVs). This finding has highlighted that the impact of necroptosis extends well beyond its cell death function. In this review, we summarize the general characteristics, biogenesis, and function of EVs, as well as their role in cancer. In addition, we outline our current knowledge regarding necroptotic EVs, including their recently discovered and analyzed proteome. We examine the accumulating evidence for a role for necroptosis in anti-tumor immunity. Finally, we suggest that necroptotic EVs play an important role in the necroptosis-induced immune response and may, therefore, be exploited in cancer immunotherapy applications.
KW - Cancer
KW - Extracellular vesicles
KW - Immunotherapy
KW - MLKL
KW - Necroptosis
KW - RIPK1
KW - RIPK3
UR - https://www.scopus.com/pages/publications/85091604203
U2 - 10.1016/j.semcdb.2020.08.011
DO - 10.1016/j.semcdb.2020.08.011
M3 - Review article
C2 - 32988742
SN - 1084-9521
VL - 109
SP - 106
EP - 113
JO - Seminars in Cell and Developmental Biology
JF - Seminars in Cell and Developmental Biology
ER -